Cell Therapies Developer Celebrates Double Award Win

A UK cellular conversion technology business held a double celebration at the 15th Annual Scrip Awards,(Dec 2019), as Mogrify received MSD’s Innovation Award and the Lifetime Achievement Award was presented to company Chair, Dr Jane Osbourn.

The Innovation Award recognised the potential of the company’s technology to transform any human cell type into any other, without going through a pluripotent stem cell- or progenitor cell-state.

Dr. Osbourn, a scientific leader in the field of antibody engineering, has more than 30 years of experience in biologics discovery and development. She has been Vice President for Research and Development and Site Leader at MedImmune (AstraZeneca), formerly Cambridge Antibody Technology (CAT), Chair of the Board of Directors of the BioIndustry Association, a Director of Babraham Bioscience Technologies and a Director of Cambridge Enterprise. She has made significant contributions to the discovery and development of phage display technology, eight marketed drugs (including HUMIRA® and BENLYSTA®) and over 40 clinical candidates. With a Dr. doctorate from the John Innes Institute in Norwich and a first-class degree in natural sciences from the University of Cambridge, she was awarded an OBE for services to drug discovery, development and biotechnology.

Dr Darrin M Disley, OBE, CEO, Mogrify, said: “Our systematic approach to the discovery of novel cell conversions has the potential to transform cell therapy. Mogrify’s technology opens up the opportunity to develop and scale up any autologous and allogeneic cell therapies, as well as create a new class of therapies: in vivo reprograming and could therefore have a significant impact on the treatment of degenerative conditions and cancers. We are proud to have our innovative platform and pioneering approach recognized by the judges.

“Dr Osbourn has contributed significantly to the industry throughout her impressive career and is globally renowned for her expertise in biologics discovery and development. She is an inspirational leader and we look forward to celebrating her exceptional achievements.”